Valneva awarded up to £20 million by scottish enterprise to advance vaccine development

Saint herblain ( france), february 21 , 2022 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced that its subsidiary valneva scotland has been awarded research and development funding of up to £20 million by scottish enterprise.
VALN Ratings Summary
VALN Quant Ranking